This study found that the hazard of NAION was 3.24 times higher in individuals exposed to the GLP-1R agonists compared with those who were not,
This study found that the hazard of NAION was 3.24 times higher in individuals exposed to the GLP-1R agonists compared with those who were not,
This study found that the hazard of NAION was 3.24 times higher in individuals exposed to the GLP-1R agonists compared with those who were not,
This study found that the hazard of NAION was 3.24 times higher in individuals exposed to the GLP-1R agonists compared with those who were not,